{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:27:26Z","timestamp":1783344446668,"version":"3.54.6"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"Introduction<\/jats:title>Hydroxysafflor yellow A (HSYA), its primary bioactive metabolite of Carthamus tinctorius L<\/jats:italic>. (safflower), has shown therapeutic potential in various inflammatory diseases. However, its role in alleviating inflammation and oxidative stress in non-alcoholic fatty liver disease (NAFLD) remains unclear. This study investigates the therapeutic effects of HSYA in mice with NAFLD, focusing on its impact on gut microbiota and serum non-targeted metabolomics to elucidate the mechanisms underlying its efficacy.<\/jats:p><\/jats:sec>Methods<\/jats:title>NAFLD was induced in mice using a high-fat diet (HFD), followed by intragastric administration of hydroxysafflor yellow A (HSYA). Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), and triglycerides (TG) were quantified to evaluate liver function and lipid metabolism. Oxidative stress markers, including superoxide dismutase (SOD) activity and malondialdehyde (MDA) concentration, were also assessed. The pro-inflammatory cytokines IL-6, TNF-\u03b1, and IL-1\u03b2 in serum were measured using ELISA. The hepatic expression of NLRP3 inflammasome and its downstream effector, Caspase-1, was analyzed by Western blot. Histopathological examination of liver tissues was performed using hematoxylin and eosin (H&amp;E) staining to evaluate structural damage. Furthermore, alterations in the gut microbiota composition were characterized via 16S rDNA sequencing of fecal samples. Untargeted metabolomics was conducted to identify serum metabolic variations and elucidate enriched metabolic pathways associated with HSYA treatment.<\/jats:p><\/jats:sec>Results<\/jats:title>HSYA significantly inhibited HFD-induced weight gain and alleviated liver inflammation. It reduced serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and triglycerides (TG) (P<\/jats:italic> &lt; 0.05). HSYA administration decreased hepatic mRNA and protein expression of nucleotide binding oligomerization domain like receptor protein 3 (NLRP3), Caspase-1 and interleukin - 1\u03b2 (IL-1\u03b2) while increasing superoxide dismutase (SOD) activity (P<\/jats:italic> &lt; 0.05). Gut microbiota analysis revealed a significant increase in the abundance of Turicibacter<\/jats:italic>, while a reduction of Ruminococcus<\/jats:italic>. Serum metabolomics identified a reduction in inflammation-associated metabolites, such as phenylalanine and tyrosine, alongside enhanced phenylalanine and tyrosine biosynthesis pathways.<\/jats:p><\/jats:sec>Discussion<\/jats:title>HSYA demonstrates potent anti-inflammatory and antioxidant effects, effectively mitigating liver inflammation and oxidative stress in NAFLD mice. Its therapeutic mechanisms may involve modulating gut microbiota and regulating serum phenylalanine and tyrosine metabolism, offering insights into its potential as a treatment for NAFLD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1568608","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T05:23:41Z","timestamp":1749187421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Hydroxysafflor yellow A alleviates oxidative stress and inflammatory damage in the livers of mice with nonalcoholic fatty liver disease and modulates gut microbiota"],"prefix":"10.3389","volume":"16","author":[{"given":"Liang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Jiajun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/antiox10020174","article-title":"Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy","volume":"10","author":"Arroyave-Ospina","year":"2021","journal-title":"Antioxidants Basel, Switz."},{"key":"B2","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.molmet.2020.101143","article-title":"Metabolic drivers of non-alcoholic fatty liver disease","volume":"50","author":"Bence","year":"2021","journal-title":"Mol. Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jsams.2020.06.002","article-title":"Is the gut microbiota bacterial abundance and composition associated with intestinal epithelial injury, systemic inflammatory profile, and gastrointestinal symptoms in response to exertional-heat stress","volume":"23","author":"Bennett","year":"2020","journal-title":"J. Sci. Med. Sport"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/antiox13020253","article-title":"Maternal malic acid may ameliorate oxidative stress and inflammation in sows through modulating gut microbiota and host metabolic profiles during late pregnancy","volume":"13","author":"Chen","year":"2024","journal-title":"Antioxidants Basel, Switz."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5937\/jomb0-24652","article-title":"The role of oxidative stress in the development of obesity and obesity-related metabolic disorders","volume":"40","author":"\u010colak","year":"2021","journal-title":"J. Med. Biochem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1379335","DOI":"10.3389\/fmed.2024.1379335","article-title":"Alterations in tryptophan metabolism and de novo NAD(+) biosynthesis within the microbiota-gut-brain axis in chronic intestinal inflammation","volume":"11","author":"Devereaux","year":"2024","journal-title":"Front. Med. (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"873555","DOI":"10.3389\/fmicb.2022.873555","article-title":"Enzyme promiscuity in serotonin biosynthesis, from bacteria to plants and humans","volume":"13","author":"Gon\u00e7alves","year":"2022","journal-title":"Front. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/nu12051450","article-title":"Changed amino acids in NAFLD and liver fibrosis: a large cross-sectional study without influence of insulin resistance","volume":"12","author":"Hasegawa","year":"2020","journal-title":"Nutrients"},{"key":"B10","doi-asserted-by":"publisher","first-page":"14281","DOI":"10.3390\/ijms232214281","article-title":"Integrating network pharmacology and transcriptomic strategies to explore the pharmacological mechanism of hydroxysafflor yellow A in delaying liver aging","volume":"23","author":"Kong","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3390\/biomedicines11041097","article-title":"Non-alcoholic fatty liver disease or type 2 diabetes mellitus-the chicken or the egg dilemma","volume":"11","author":"Kosmalski","year":"2023","journal-title":"Biomedicines"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7805393","DOI":"10.1155\/2020\/7805393","article-title":"Protective effect of hydroxysafflor yellow A on nephropathy by attenuating oxidative stress and inhibiting apoptosis in induced type 2 diabetes in rat","volume":"2020","author":"Lee","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"11503","DOI":"10.1039\/d2fo02051c","article-title":"Jerusalem artichoke inulin supplementation ameliorates hepatic lipid metabolism in type 2 diabetes mellitus mice by modulating the gut microbiota and fecal metabolome","volume":"13","author":"Li","year":"","journal-title":"Food Funct."},{"key":"B14","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41598-020-58048-w","article-title":"Inulin with different degrees of polymerization protects against diet-induced endotoxemia and inflammation in association with gut microbiota regulation in mice","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.14336\/AD.2022.0318","article-title":"Non-alcoholic fatty liver disease and liver fibrosis during aging","volume":"13","author":"Li","year":"","journal-title":"Aging Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/eji.202149401","article-title":"Tryptophan and the innate intestinal immunity: crosstalk between metabolites, host innate immune cells, and microbiota","volume":"52","author":"Li","year":"","journal-title":"Eur. J. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.tem.2021.04.008","article-title":"Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease","volume":"32","author":"Lim","year":"2021","journal-title":"Trends Endocrinol. metabolism TEM"},{"key":"B18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.phrs.2018.05.012","article-title":"Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism","volume":"134","author":"Liu","year":"2018","journal-title":"Pharmacol. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"810143","DOI":"10.3389\/fphys.2022.810143","article-title":"Polyene phosphatidylcholine ameliorates high fat diet-induced non-alcoholic fatty liver disease via remodeling metabolism and inflammation","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1038\/s41467-023-39403-7","article-title":"Gut microbiota Turicibacter strains differentially modify bile acids and host lipids","volume":"14","author":"Lynch","year":"2023","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"111692","DOI":"10.1016\/j.intimp.2024.111692","article-title":"Indoleamine 2, 3-dioxygenase 1 activation in macrophage exacerbates hepatic ischemia-reperfusion injury by triggering hepatocyte ferroptosis","volume":"130","author":"Ma","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e000368","DOI":"10.1136\/bmjgast-2019-000368","article-title":"Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia","volume":"7","author":"Maev","year":"2020","journal-title":"BMJ Open Gastroenterol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/metabo10060253","article-title":"A metabolic perspective and opportunities in pharmacologically important safflower","volume":"10","author":"Mani","year":"2020","journal-title":"Metabolites"},{"key":"B24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/antiox13070797","article-title":"The role of antioxidants in the treatment of metabolic dysfunction-associated fatty liver disease: a systematic review","volume":"13","author":"Mohammadian","year":"2024","journal-title":"Antioxidants Basel, Switz."},{"key":"B26","doi-asserted-by":"publisher","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"key":"B27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e00466","DOI":"10.14309\/ctg.0000000000000466","article-title":"Relationship between hepatic gene expression, intestinal microbiota, and inferred functional metagenomic analysis in NAFLD","volume":"13","author":"Pettinelli","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.3390\/cells10123401","article-title":"Progressive liver fibrosis in non-alcoholic fatty liver disease","volume":"10","author":"Ramai","year":"2021","journal-title":"Cells"},{"key":"B30","doi-asserted-by":"publisher","first-page":"917966","DOI":"10.3389\/fimmu.2022.917966","article-title":"Associations of microbial and indoleamine-2,3-dioxygenase-derived tryptophan metabolites with immune activation in healthy adults","volume":"13","author":"Riazati","year":"2022","journal-title":"Front. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterology and Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13054-022-04174-y","article-title":"Circulating N-formylmethionine and metabolic shift in critical illness: a multicohort metabolomics study","volume":"26","author":"Sigurdsson","year":"2022","journal-title":"Crit. care London, Engl."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1017\/jns.2020.39","article-title":"Associations between dietary total antioxidant capacity and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study","volume":"9","author":"Sohouli","year":"2020","journal-title":"J. Nutr. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.3390\/molecules28104042","article-title":"Lactiplantibacillus plantarum NKK20 alleviates high-fat-diet-induced nonalcoholic fatty liver disease in mice through regulating bile acid anabolism","volume":"28","author":"Sun","year":"2023","journal-title":"Molecules"},{"key":"B35","doi-asserted-by":"publisher","first-page":"729","DOI":"10.21037\/atm-20-4354","article-title":"Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention","volume":"9","author":"Tacke","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/metabo12060514","article-title":"Interactions between tryptophan metabolism, the gut microbiome and the immune system as potential drivers of non-alcoholic fatty liver disease (NAFLD) and metabolic diseases","volume":"12","author":"Teunis","year":"2022","journal-title":"Metabolites"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1495393","DOI":"10.3389\/fphar.2024.1495393","article-title":"Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"734539","DOI":"10.3389\/fphar.2021.734539","article-title":"Hydroxy-safflower yellow A alleviates osteoporosis in ovariectomized rat model by inhibiting carbonic anhydrase 2 activity","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"767947","DOI":"10.3389\/fphar.2021.767947","article-title":"Extraction, structures, bioactivities and structure-function analysis of the polysaccharides from Safflower (Carthamus tinctorius L.)","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"153694","DOI":"10.1016\/j.phymed.2021.153694","article-title":"Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis","volume":"91","author":"Xue","year":"2021","journal-title":"Phytomedicine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3389\/fphar.2020.00482","article-title":"Safflower yellow and its main component HSYA alleviate diet-induced obesity in mice: possible involvement of the increased antioxidant enzymes in liver and adipose tissue","volume":"11","author":"Yan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"114040","DOI":"10.1016\/j.intimp.2025.114040","article-title":"Hydroxysafflor yellow A attenuates the inflammatory response in cerebral ischemia-reperfusion injured mice by regulating microglia polarization per SIRT1-mediated HMGB1\/NF-\u03baB signaling pathway","volume":"147","author":"Yao","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"101168","DOI":"10.1016\/j.bbrep.2021.101168","article-title":"Metformin treatment reverses high fat diet-induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways","volume":"28","author":"Yasmin","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"fnad016","DOI":"10.1093\/femsle\/fnad016","article-title":"Romboutsia lituseburensis JCM1404 supplementation ameliorated endothelial function via gut microbiota modulation and lipid metabolisms alterations in obese rats","volume":"370","author":"Yin","year":"2023","journal-title":"FEMS Microbiol. Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1063035","DOI":"10.3389\/fphar.2022.1063035","article-title":"Protective potential of hydroxysafflor yellow A in cerebral ischemia and reperfusion injury: an overview of evidence from experimental studies","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"579332","DOI":"10.3389\/fphar.2020.579332","article-title":"Hydroxysafflor yellow A: a systematical review on botanical Resources, physicochemical properties, drug delivery system, pharmacokinetics, and pharmacological effects","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"127308","DOI":"10.1016\/j.ijbiomac.2023.127308","article-title":"Flammulina velutipes polysaccharides regulate lipid metabolism disorders in HFD-fed mice via bile acids metabolism","volume":"253","author":"Zhao","year":"2023","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1568608\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T05:23:41Z","timestamp":1749187421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1568608\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":49,"alternative-id":["10.3389\/fphar.2025.1568608"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1568608","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"article-number":"1568608"}}